Andrographolide suppresses proliferation of nasopharyngeal carcinoma cells via attenuating NF-κB pathway

Area of Science:

• Oncology
• Pharmacology
• Molecular Biology

Background:

• Andrographolide (Andro) exhibits anticancer properties in various cancers by inhibiting the NF-κB pathway.
• The NF-κB pathway is a potential therapeutic target in nasopharyngeal carcinoma (NPC).
• The specific anticancer effects of Andro in NPC remain underexplored.

Purpose of the Study:

• To investigate the anticancer effects of Andrographolide (Andro) in nasopharyngeal carcinoma (NPC) cells.
• To elucidate the underlying mechanisms of Andro's action in NPC.
• To evaluate the role of the NF-κB pathway in Andro-mediated anticancer activity.

Main Methods:

• Cell proliferation and invasion assays were performed on NPC cells treated with Andro.
• Mechanisms including apoptosis, cell death, and cell cycle arrest were analyzed.
• The expression of NF-κB target genes was assessed to understand pathway involvement.

Main Results:

• Andrographolide (Andro) significantly inhibited NPC cell proliferation and invasion (P < 0.05).
• Anticancer effects were associated with increased apoptosis, cell death, and cell cycle arrest.
• Downregulation of NF-κB target genes was observed, indicating pathway inhibition.

Conclusions:

• Andrographolide (Andro) demonstrates significant anticancer activity against nasopharyngeal carcinoma (NPC) cells.
• The NF-κB pathway is implicated in Andro's mechanism of action in NPC.
• Targeting the NF-κB pathway is a promising therapeutic strategy for NPC.